Skip to main content

Agile Therapeutics Inc

AGRXDelisted Jun 3, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001261249

Agile Therapeutics Inc was delisted on Jun 3, 2024; its insiders filed their last Form 4 on Aug 26, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $496.2K in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Agile Therapeutics Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AGRX: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders7154−17
Shares34.4M31.8M−2.60M (−7.6%)
Value$45.7M$30.5M−$15.2M (−33.2%)

New holders (2)

Institutions that held Agile Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AGRX in Q3 2021
InstitutionSharesValue% of portfolio
Parsec Financial Management, Inc.11,000$8.00K0.00%
FMR LLC10$00.00%

Sold out (19)

Institutions that held Agile Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.